Abstract
The association between bronchial carcinoma and cigarette smoking is well known (Doll and Hill, 1952; 1964) but, while smokers carry a much higher risk of lung cancer than non-smokers, the majority of them escape this disease. A substantial variation in individual susceptibility to the carcinogenic effects of smoking must therefore be present in the population.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen, J.G., East, P.B., Francis, R.J. and Haigh, J.L., 1975, Metabolism of debrisoquine: identification of some urinary metabolites in rat and man. Drug Metab. Disp., 3: 332.
Angelo, M., Dring, L.G., Lancaster, R., Latham, A. and Smith, R.L., 1975, The metabolism of debrisoquine in rat and man. Br. J. Pharmacol., 55: 264 P.
Danhof, M., 1980, Antipyrine metabolite profile as a tool in the assessment of the activity of different drug oxidizing enzymes in man. Ph.D. Thesis, Univ. of Leiden.
Doll, R. and Hill, A.B., 1952, A study of the aetiology of carcinoma of the lung, Br. Med. J., 2: 1271.
Ibid., 1964, Mortality in relation to smoking, Br. Med. J., 1: 1399.
Evans, D.A.P., Mahgoub, A., Sloan, T.P., Idle, J.R. and Smith, R.L., 1980, A family and population study of the genetic polymorphism of debrmsoquine metabolism in a British White population, J. Med. Genet. 17: 102.
Idle, J.R., Mahgoub, A., Angelo, M.M., Dring, L.G., Lancaster, R. and Smith, R.L., 1979a, The metabolism of debrisoquine in man, Br. J. Clin, Pharmacol, 7: 257.
Idle, J.R., Sloan, T.P., Smith, R.L. and Wakile, L.A., 1979b, The application of the phenotyped panel approach to the detection of polymorphism of drug oxidation in man. Br. J. Pharmacol., 66: 430 P.
Idle, J.R. and Smith, R.L., 1979, Polymorphism of oxidation at carbon centres of drugs and their clinical significance, Drug Metab. Rev., 9: 301.
Kellerman, G., Kellerman, L.M. and Shaw, C.R., 1973a, Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am. J. Hum. Genet. 25: 327.
Kellerman, G., Shaw, C.R. and Kellerman, L.M., 1973b, Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med. 289: 934.
Mahgoub, A., Idle, J.R., Dring, L.G., Lancaster, R. and Smith, R.L. 1977, Polymorphic hydroxylation of debrisoquine in man, Lancet, ii: 584.
Miller, J.A., 1974, in: “The induction of Drug metabolism, Symposia Medica Hoechst 14”, R.W. Estabrook, E. Lindenlaub, eds., Shattauer Verlag, Stuttgart-New York.
Shah, R.R., Oates, N.S., Idle, J.R. and Smith, R.L., 1980, Genetic impairment of phenformin metabolism. Lancet i: 1147.
Sloan, T.P., Mahgoub, A., Lancaster, R., Idle, J.R. and Smith, R.L. 1978, Polymorphism of carbon oxidation of drugs and clinical implications, Br. Med. J., 2: 655.
Wakile, L.A., Sloan, T.P., Idle, J.R. and Smith, R.L., 1979, Genetic evidence for the involvement of different oxidative mechanisms in drug oxidation. J. Pharm. Pharmacol. 31: 350.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Hetzel, M.R., Law, M., Keal, E.E., Sloan, T.P., Idle, J.R., Smith, R.L. (1982). Inborn Susceptibility/Resistance to Lung Cancer. In: Cumming, G., Bonsignore, G. (eds) Cellular Biology of the Lung. Ettore Majorana International Science Series, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3403-3_27
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3403-3_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3405-7
Online ISBN: 978-1-4613-3403-3
eBook Packages: Springer Book Archive